Your search matched 5 results
While pharmaceutical manufacturers need to continue engaging with the broader healthcare system to help address healthcare disparities in the long term, there is action they can take now.
Real world evidence: what it is, what it is important, and what it means for healthcare communicators.
CMS has recently finalized a rule that aims to save beneficiaries and pharmaceutical manufactures money.
For many patients, receiving care right away is of vital importance.
Financial toxicity decreases cancer patients’ quality of life – but early identification and strategic planning can mitigate the impact overall.